Literature DB >> 32514558

Report on a New Opioid NPS: Chemical and In Vitro Functional Characterization of a Structural Isomer of the MT-45 Derivative Diphenpipenol.

Annelies Cannaert1, Fabian Hulpia2, Martijn Risseeuw2, Katleen Van Uytfanghe1, Eric Deconinck3, Serge Van Calenbergh2, Peter Blanckaert4, Christophe Stove1.   

Abstract

In this paper, the identification and full characterization of a novel non-fentanyl opioid sourced online, which is a member of the 1-substituted-4-(1,2-diphenylethyl)piperazine derivatives related to MT-45, is reported. The sample was sold under the name "diphenpipenol," (3-[2-[4-(2-methoxyphenyl)piperazin-1-yl]-2-phenylethyl]phenol), although extensive NMR analysis showed that the product obtained was actually a diphenpipenol structural isomer, (2-[4-(2-methoxyphenyl)piperazin-1-yl]-1,2-diphenylethanol). Liquid chromatography time-of-flight mass spectrometry identified an exact mass for the protonated molecule of m/z 389.2264, with two prominent fragment ions (m/z 91.0567 and 150.0937), which were not reported in earlier literature describing MT-45 derivatives. The chemical characterization was finalized by gas chromatography-mass spectrometry, high-performance liquid chromatography diode array detector and Fourier-transform infrared spectroscopy analyses. This product is a clear example of the trend that new non-fentanyl opioids are reappearing on the recreational drug market to escape the recent changes in (inter)national legislation concerning fentanyl analogues. Although in this particular case, the product's potency and efficacy were relatively low, other new non-fentanyl opioids might possess stronger potencies and therefore pose greater health risks for ignorant users. The fact that the product was sold under the wrong name further demonstrates the well-known problematic issue of a mismatch between the adverted and true identity, confirming the irregularities of the online new psychoactive substances market.
© The Author(s) 2020. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oup.com.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 32514558     DOI: 10.1093/jat/bkaa066

Source DB:  PubMed          Journal:  J Anal Toxicol        ISSN: 0146-4760            Impact factor:   3.367


  3 in total

Review 1.  Reports of Adverse Events Associated with Use of Novel Psychoactive Substances, 2017-2020: A Review.

Authors:  Amanda L A Mohr; Barry K Logan; Melissa F Fogarty; Alex J Krotulski; Donna M Papsun; Sherri L Kacinko; Marilyn A Huestis; Jeri D Ropero-Miller
Journal:  J Anal Toxicol       Date:  2022-07-14       Impact factor: 3.220

2.  Identifying New/Emerging Psychoactive Substances at the Time of COVID-19; A Web-Based Approach.

Authors:  Valeria Catalani; Davide Arillotta; John Martin Corkery; Amira Guirguis; Alessandro Vento; Fabrizio Schifano
Journal:  Front Psychiatry       Date:  2021-02-09       Impact factor: 4.157

Review 3.  Non-fentanyl-derived synthetic opioids emerging during recent years.

Authors:  Koutaro Hasegawa; Kayoko Minakata; Masako Suzuki; Osamu Suzuki
Journal:  Forensic Toxicol       Date:  2022-04-29       Impact factor: 2.541

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.